Medicure Inc. (CVE:MPH – Get Free Report) shares passed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of C$1.16 and traded as high as C$1.34. Medicure shares last traded at C$1.34, with a volume of 100 shares changing hands.
Medicure Trading Down 0.7%
The company has a market capitalization of C$13.98 million, a P/E ratio of -4.06 and a beta of 1.09. The company has a 50-day simple moving average of C$1.16 and a 200 day simple moving average of C$1.14. The company has a debt-to-equity ratio of 4.65, a quick ratio of 1.29 and a current ratio of 2.03.
Medicure Company Profile
Medicure Inc, a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction.
Recommended Stories
- Five stocks we like better than Medicure
- Why Are Stock Sectors Important to Successful Investing?
- 3 Stocks Poised to Benefit From Google’s AI Breakthough
- CD Calculator: Certificate of Deposit Calculator
- Beyond NVIDIA: 5 Semiconductor Stocks Set to Dominate 2026
- Pets Are Big Business: 4 Big-Ticket Pet Stocks to Add to Your Portfolio
- 3 Stocks You’ll Wish You Bought Before 2026
Receive News & Ratings for Medicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicure and related companies with MarketBeat.com's FREE daily email newsletter.
